Daily News Journal: Loss of Drug Pricing Program Would Hurt At-Risk Patients | 340B Matters
16052
post-template-default,single,single-post,postid-16052,single-format-standard,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

25 Aug Daily News Journal: Loss of Drug Pricing Program Would Hurt At-Risk Patients

The health care industry is undergoing dramatic transformation as we shift from fee-for-service reimbursement to a fee-for-value payment system, promoting the value and outcome of the health care services we deliver. We’re focused on providing the best care for the people we serve, measuring the efficiency of our health care delivery and striving to improve outcomes at a lower cost.

At Saint Thomas and Ascension, the nation’s leading nonprofit health care system, we have embraced this transformation because it’s the right thing to do for the communities we serve. Unfortunately, one of the biggest daily obstacles that we see to providing better care at a lower cost is the astronomical price increases of prescription drugs.

Read More

 

 

Want To Stay Up-To-Date On The Latest 340B News?